CG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
Recognition reflects sustained growth, strategic expansion, and continued investment in the future of life science communications
CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare, specialty, and hard-to-treat diseases to market, has been named to the 2026 Inc. 5000, an annual ranking of the fastest-growing private companies in America.
The national honor recognizes CG Life for its continued business growth and significant expansion of its role as a commercialization partner for biopharma companies. Last month, CG Life combined with AI-native pharma agency, The Considered+AI. The union brings together deep scientific and commercialization expertise, an AI-native operating model, and world-class talent to help clients bring breakthrough therapies to market with greater speed, precision, and impact.
“This recognition by Inc. alongside so many of the country’s most dynamic, high-growth companies is a testament to the talented people at CG Life who bring their best every day,” said David Ormesher, CEO of CG Life. “Our industry is changing quickly. Science and technology are moving faster, product launches are getting more complex, and our clients need tighter relationships with their agency partners. We’ve been very deliberate about where we invest and the kind of company we’re building, so this honor from Inc. is a validation that we’re on the right path.”
